IL13 and ovarian cancer: Human breast and renal cancer cell lines treated with exogenous IL-13 in vitro demonstrate reduced proliferation (168–170) – although an ovarian cancer line demonstrated enhanced invasive and enzyme (protease) activity (171) suggesting IL-13 aids primary tumor invasion and metastasis in this model.